Alan Christy Hunter

Cited by

	All	Since 2018
Citations	14683	4405
h-index	39	25
i10-index	65	40

1200

600

300

900

200220032004200520062007200820092010201120122013201420152016201720182019202020212022202350 88 115 185 377 450 495 596 664 854 966 1051 1161 1022 1107 996 886 781 800 780 708 446

Public access

View all

10 articles

6 articles

available

not available

Based on funding mandates

Co-authors

SM MoghimiProfessor of Pharmaceutics and Nanomedicine; School of Pharmacy and Institute of Cellular MedicineVerified email at ncl.ac.uk
Thomas L. AndresenProfessor, Technical University of DenmarkVerified email at nanotech.dtu.dk
Adam SzewczykProfessor of Biochemistry, Nencki Institute of Experimental BiologyVerified email at nencki.edu.pl
Janos SzebeniNanomedicine Research and Education Center, Semmelweis UniversityVerified email at seroscience.com
Islam HamadAssociate Professor of NanomedicineVerified email at aum.edu.jo
Davoud Ahmadvandiran university of medical sciencesVerified email at iums.ac.ir
Andrew LloydProfessor of Biomedical MaterialsVerified email at brighton.ac.uk
Hongjie DaiProfessor of chemistry, stanford universityVerified email at stanford.edu
Simon Paul HardyUniversity of BrightonVerified email at brighton.ac.uk
Dipak K SarkerAssociate Professor in Materials Science, University of BrightonVerified email at brighton.ac.uk
Kenton M SandersUniversity of Nevada, RenoVerified email at med.unr.edu
Flemming BesenbacherProfessor in nanosceince and physics, Aarhus University; Chairman of the Carlsberg FoundationVerified email at inano.au.dk
Dan PeerProf. of NanoMedicine and Immunology, Tel Aviv UniversityVerified email at post.tau.ac.il
Jonathan D. LippiatUniversity of LeedsVerified email at leeds.ac.uk
İsmail KIRANEskişehir Osmangazi UniversityVerified email at ogu.edu.tr
Richard A. BryceDivision of Pharmacy and Optometry, University of ManchesterVerified email at manchester.ac.uk
Christopher F. BlanfordSenior Lecturer, Univ. Manchester, Dept. of Materials & Manchester Institute of BiotechnologyVerified email at manchester.ac.uk
Fan FeiSchool of Materials, The University of ManchesterVerified email at manchester.ac.uk
Richard WinpennyProfessor of Inorganic Chemistry, The University of ManchesterVerified email at manchester.ac.uk
Dr Steven Meikle

Alan Christy Hunter

Associate Professor in Pharmaceutics (Drug Delivery and Nanomedicine)

Verified email at lincoln.ac.uk

Nanomedicine Complement Biocatalysis Steroids


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Long-circulating and target-specific nanoparticles: theory to practice SM Moghimi, AC Hunter, JC Murray Pharmacological reviews 53 (2), 283-318, 2001	4613	2001
Nanomedicine: current status and future prospects SM Moghimi, AC Hunter, JC Murray The FASEB journal 19 (3), 311-330, 2005	2609	2005
A two-stage poly (ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy SM Moghimi, P Symonds, JC Murray, AC Hunter, G Debska, A Szewczyk Molecular therapy 11 (6), 990-995, 2005	1228	2005
Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective SM Moghimi, AC Hunter, TL Andresen Annual review of pharmacology and toxicology 52, 481-503, 2012	555	2012
Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity AC Hunter Advanced drug delivery reviews 58 (14), 1523-1531, 2006	516	2006
Poloxamers and poloxamines in nanoparticle engineering and experimental medicine SM Moghimi, AC Hunter Trends in biotechnology 18 (10), 412-420, 2000	500	2000
Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere− serum interface: implications for stealth nanoparticle engineering I Hamad, O Al-Hanbali, AC Hunter, KJ Rutt, TL Andresen, SM Moghimi ACS nano 4 (11), 6629-6638, 2010	292	2010
Poly (ethylene glycol) s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process I Hamad, AC Hunter, J Szebeni, SM Moghimi Molecular immunology 46 (2), 225-232, 2008	278	2008
Material properties in complement activation SM Moghimi, AJ Andersen, D Ahmadvand, PP Wibroe, TL Andresen, ... Advanced drug delivery reviews 63 (12), 1000-1007, 2011	270	2011
Agricultural robotics: the future of robotic agriculture T Duckett, S Pearson, S Blackmore, B Grieve, WH Chen, G Cielniak, ... arXiv preprint arXiv:1806.06762, 2018	266	2018
Polycation cytotoxicity: a delicate matter for nucleic acid therapy—focus on polyethylenimine L Parhamifar, AK Larsen, AC Hunter, TL Andresen, SM Moghimi Soft Matter 6 (17), 4001-4009, 2010	237	2010
Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups SM Moghimi, AC Hunter Pharmaceutical research 18, 1-8, 2001	191	2001
Complement activation cascade triggered by PEG–PL engineered nanomedicines and carbon nanotubes: The challenges ahead SM Moghimi, AJ Andersen, SH Hashemi, B Lettiero, D Ahmadvand, ... Journal of controlled release 146 (2), 175-181, 2010	184	2010
PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance JK Gbadamosi, AC Hunter, SM Moghimi FEBS letters 532 (3), 338-344, 2002	180	2002
Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes PP Wibroe, AC Anselmo, PH Nilsson, A Sarode, V Gupta, R Urbanics, ... Nature nanotechnology 12 (6), 589-594, 2017	163	2017
Cationic carriers of genetic material and cell death: a mitochondrial tale AC Hunter, SM Moghimi Biochimica et Biophysica Acta (BBA)-Bioenergetics 1797 (6-7), 1203-1209, 2010	151	2010
Causative factors behind poloxamer 188 (Pluronic F68, Flocor™)-induced complement activation in human sera: A protective role against poloxamer-mediated complement activation … SM Moghimi, AC Hunter, CM Dadswell, S Savay, CR Alving, J Szebeni Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1689 (2), 103-113, 2004	150	2004
Low and high molecular weight poly (l-lysine) s/poly (l-lysine)–DNA complexes initiate mitochondrial-mediated apoptosis differently P Symonds, JC Murray, AC Hunter, G Debska, A Szewczyk, SM Moghimi FEBS letters 579 (27), 6191-6198, 2005	147	2005
Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective AC Hunter, J Elsom, PP Wibroe, SM Moghimi Maturitas 73 (1), 5-18, 2012	141	2012
Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover I Hamad, AC Hunter, KJ Rutt, Z Liu, H Dai, SM Moghimi Molecular immunology 45 (14), 3797-3803, 2008	139	2008

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors